1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Digital Pathology: Technologies and Global Markets

Digital Pathology: Technologies and Global Markets

  • February 2016
  • -
  • BCC Research
  • -
  • 193 pages

This BCC Research report includes projected trends and sales in the digital pathology and telepathology markets through 2020. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed.

Use this report to:

Analyze forecasted trends and sales in the digital pathology and telepathology markets.
Analyze competitive intelligence and regional trends in digital pathology market.
Receive information about the key market participants, extensive product segments, supporting technologies, and market dynamics of digital pathology and telepathology.
Receive information about the diagnostic, research and development (R&D), and education and training applications related to Telepathology

Highlights

The global digital pathology market will grow from nearly $3.2 billion in 2015 to nearly $6.5 billion by 2020 with a compound annual growth rate (CAGR) of 15.0% for the period of 2015-2020.
The North American market will grow from $1.3 billion in 2015 to nearly $2.5 billion by 2020 with a CAGR of 13.3%.
The European market is the second largest digital pathology market and will grow from $1.1 billion in 2015 to $1.9 billion by 2020 with a CAGR of 12.2%.

STUDY BACKGROUND

The role of a conventional laboratory is to focus on cost savings, increased laboratory workload and innovative technologies, such as m-health. Digital pathology and telepathology are seen as effective solutions with significant scopes to address the prevailing issues of cost, time and technology. Digital pathology and telepathology offer improved connectivity and reduce healthcare costs. Successful and consistent adoption of digital pathology and telepathology in developed economies is encouraging the developing economies to experiment as well.

The creation of disciplined regulatory environments that protect patient safety and focus on electronic medical records (EMRs), the need for quick diagnoses and the maintenance of cost issues will drive the market. The evolving market, however, presents significant challenges, including significant deployment costs, U.S. Food and
Drug Administration (FDA) approvals, technological complexities, and a lack of skilled staff and conventional pathologists.

The scenario is very different in developing economies, where the concepts of telepathology and digital pathology are so far relevant only to niche and reputed laboratories. There are significant complexities involved in the process of enabling the adoption of novel technologies. Technology providers are having difficulty meeting
varied customer expectations in different regions with respect to the products or services they offer, price and quality. This requires a deeper understanding of the existing infrastructure and process, cost-versus-value expectations, regulatory issues and other driving forces. This report addresses these issues and provides a
comprehensive and objective study to enhance the market presence of participants such as digital pathology technology providers, product manufacturers, service providers, system integrators and other key value chain members.

SCOPE OF THE REPORT

This report includes forecasted trends and sales in the digital pathology and telepathology markets through 2020. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends and competitive scenarios that will form the base data for qualitative analysis and market estimates.

The digital pathology and telepathology market has been analyzed for the four main geographic regions: North America, Europe, Asia and the rest of the world (ROW).

The report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and
information generated from pathology labs and that regarding specific diagnosis, but it will exclude general hospital-based m-health issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.

Table Of Contents

Digital Pathology: Technologies and Global Markets
CHAPTER 1 INTRODUCTION 2
STUDY AND OBJECTIVE 2
STUDY BACKGROUND 2
SCOPE OF THE REPORT 3
INTENDED AUDIENCE 3
SOURCE OF INFORMATION AND METHODOLOGY 4
ANALYST'S CREDENTIALS 4
RELATED BCC RESEARCH REPORTS 5
BCC RESEARCH WEBSITE 5
DISCLAIMER 5
CHAPTER 2 EXECUTIVE SUMMARY 7
SUMMARY TABLE GLOBAL DIGITAL PATHOLOGY MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 8
SUMMARY FIGURE GLOBAL DIGITAL PATHOLOGY MARKET BY REGION, 2014-2020
($ MILLIONS) 8
CHAPTER 3 MARKET OVERVIEW 12
CURRENT TRENDS IN DIGITAL PATHOLOGY 12
COLLABORATIONS TO DEVELOP BETTER SOLUTIONS 12
INNOVATIONS TO SURGE MARKET GROWTH 12
CLOUD COMPUTING TO ENHANCE HEALTHCARE DELIVERY SYSTEMS 13
TELEPATHOLOGY AND DIGITAL PATHOLOGY: MARKET DEFINITION, EVOLUTION
AND INTEGRATION 13
FIGURE 1 TELEPATHOLOGY AND DIGITAL PATHOLOGY APPLICATIONS 15
CONVENTIONAL PROCESS VERSUS DIGITAL PATHOLOGY AND COST WORKS 16
FIGURE 2 COST ANALYSIS OF CONVENTIONAL LABS VERSUS DIGITAL PATHOLOGY
SYSTEMS 19
IMAGE ANALYSIS AND ITS IMPORTANCE IN KEY RESEARCH AREAS 19
DIGITAL PATHOLOGY IN CLINICAL TRIALS 20
DIGITAL PATHOLOGY: ELECTRONIC HEALTH RECORDS, ELECTRONIC MEDICAL
RECORDS AND OTHER INFORMATION SYSTEMS 21
REGULATORY ENVIRONMENT 22
U.S. FOOD AND DRUG ADMINISTRATION 22
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT 24
CLINICAL LABORATORY IMPROVEMENT AMENDMENTS 24
HEALTHCARE POLICIES: OBAMA MANDATORY 24
REIMBURSEMENT ISSUES 25
TECHNOLOGY TRENDS 26
SCANNING SPEEDS AND IMAGE RESOLUTIONS 28
VIEWING ADVANCEMENTS AND CLINICAL DECISION SUPPORT 28
ARCHIVAL STANDARDS 28
MULTI-SITE COLLABORATION APPLICATIONS 28
WHOLE-SLIDE DIGITAL IMAGING 28
CLOUD COMPUTING AND DIGITAL PATHOLOGY 29
LABORATORY INFORMATION SYSTEMS 30
DIGITAL PATHOLOGY: DEVELOPED VERSUS DEVELOPING ECONOMIES 30
MARKET INTELLIGENCE 31
TECHNOLOGY TRANSITION: DIGITAL PATHOLOGY COMPONENTS TO
INTEGRATED SYSTEMS 33
FIGURE 3 DIGITAL PATHOLOGY SYSTEM MARKET, THROUGH 2020 ($ MILLIONS/%) 34
AGREEMENTS AND COLLABORATIONS TO ENHANCE PRESENCE IN IMAGING
APPLICATIONS 34
FIGURE 4 KEY STRATEGIES, 2011-2015 (%) 34
FIGURE 5 KEY COMPANIES, 2011-2015 (%) 35
U.S. AS THE BASE FOR DIGITAL PATHOLOGY SYSTEM INNOVATION 37
FIGURE 6 GLOBAL PATENTS BY REGION, 2011-2015 (%) 37
FIGURE 7 GLOBAL PATENTS BY TECHNOLOGY, 2011-2015 (%) 37
STRATEGIC CONCLUSIONS 39
CASE STUDIES 40
CASE STUDY 1: DIGITAL PATHOLOGY ENABLING CRITICAL DIAGNOSIS 40
Background 40
Challenge 40
Solution 40
CASE STUDY 2: INITIATIVES AND EXAMPLES OF TELEPATHOLOGY
DEPLOYMENT IN DEVELOPING ECONOMIES 41
Cost-Related Issues 41
Hindrances for Telepathology in Developing Economies 41
Solutions for Developing Countries 42
CASE STUDY 3: DIGITAL PATHOLOGY'S ROLE IN COST SAVINGS AMONG
BIG PHARMA COMPANIES 42
CASE STUDY 4: DIGITAL PATHOLOGY IN RESOURCE POOR SETTINGS 43
MARKET DYNAMICS 43
DRIVERS 43
Cost-Effectiveness Drives Expansion 43
CASE STUDY 5: A FINANCIAL PROJECTION FOR DIGITAL PATHOLOGY
IMPLEMENTATION AT A LARGE INTEGRATED HEALTH CARE ORGANIZATION 44
Background 44
Challenge 44
Solution 44
Case Transport 44
Better Image Analysis and Analytics 45
Increasing Adoption 45
Workflow Efficiency 46
System Benefits 47
Remote Diagnosis 47
Greater Efficiency 47
RESTRAINTS 48
CHALLENGES AND OPPORTUNITIES 48
CHAPTER 4 DIGITAL PATHOLOGY SYSTEM MARKET 51
TABLE 1 GLOBAL DIGITAL PATHOLOGY MARKET BY SYSTEM, THROUGH 2020 ($
MILLIONS) 52
DEVICES MARKET 52
TABLE 2 GLOBAL DIGITAL PATHOLOGY DEVICE MARKET BY TYPE, THROUGH 2020
($ MILLIONS) 52
TABLE 3 GLOBAL DIGITAL PATHOLOGY DEVICE MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 53
VIRTUAL MICROSCOPY AND VIRTUAL SLIDES 53
Legal Status 54
Advantages 54
Disadvantages 54
Challenges 54
DIGITAL CAMERAS 55
Advantages 55
TABLE 4 GLOBAL DIGITAL CAMERAS IN THE DIGITAL PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 55
ROBOTIC MICROSCOPES 56
Advantages of robotic microscopy 56
Disadvantages of robotic microscopy 56
Hindrances 57
IMAGE SENSORS 57
TABLE 5 GLOBAL ROBOTIC MICROSCOPES IN DIGITAL PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 58
SCANNERS 58
TABLE 6 GLOBAL SCANNERS IN DIGITAL PATHOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 59
DIGITAL PATHOLOGY ANALYTIC MARKET 60
TABLE 7 GLOBAL DIGITAL PATHOLOGY ANALYTIC MARKET BY PLATFORM,
THROUGH 2020 ($ MILLIONS) 61
TABLE 8 GLOBAL DIGITAL PATHOLOGY ANALYTIC MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 61
VISUALIZATION AND IMAGE ANALYSIS PLATFORMS 62
Applications for Image Analysis in Pathology 63
Drivers for Automated Image Analysis Market 63
Images Required by Analyzer 63
Correlation of Image Data with Different Data Sources 64
Quantification of More Complex Tissue Features and Morphology
Analysis 64
TABLE 9 GLOBAL DIGITAL PATHOLOGY VISUALIZATION AND IMAGE ANALYSIS
PLATFORM MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 64
DIGITAL PATHOLOGY INFORMATION MANAGEMENT SYSTEMS 64
Digital Image Management in Pathology 65
TABLE 10 GLOBAL DIGITAL PATHOLOGY INFORMATION SYSTEM MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 66
DIGITAL PATHOLOGY STORAGE AND COMMUNICATION PLATFORM MARKET 67
TABLE 11 GLOBAL DIGITAL PATHOLOGY STORAGE PLATFORM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 69
TABLE 12 GLOBAL DIGITAL PATHOLOGY COMMUNICATION PLATFORM MARKET,
THROUGH 2020 ($ MILLIONS) 69
COMMUNICATION PLATFORM 69
WEB-BASED OR CLOUD-BASED COMMUNICATION PLATFORMS IN DIGITAL
PATHOLOGY 70
TABLE 13 GLOBAL DIGITAL PATHOLOGY COMMUNICATION PLATFORM MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 71
TELEPATHOLOGY SYSTEMS 71
TABLE 14 GLOBAL TELEPATHOLOGY SYSTEM MARKET BY TYPE, THROUGH 2020 ($
MILLIONS) 72
TABLE 15 GLOBAL TELEPATHOLOGY SYSTEM MARKET BY REGION, THROUGH 2020
($ MILLIONS) 72
KEY ADVANTAGES OF TELEPATHOLOGY SYSTEMS 73
STATIC IMAGE-BASED SYSTEMS 73
TABLE 16 GLOBAL STATIC TELEPATHOLOGY SYSTEM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 74
HYBRID TELEPATHOLOGY SYSTEMS 75
Hybrid Telepathology System Applications 75
TABLE 17 GLOBAL HYBRID TELEPATHOLOGY SYSTEM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 76
REAL-TIME TELEPATHOLOGY IMAGING SYSTEM 76
Applications 77
TABLE 18 GLOBAL REAL-TIME TELEPATHOLOGY SYSTEM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 78
CHAPTER 5 IN VITRO DIAGNOSTIC AND OTHER DIAGNOSTIC DEVICES IN DIGITAL
PATHOLOGY MARKET 80
TABLE 19 GLOBAL DIGITAL IN VITRO AND OTHER DIAGNOSTIC DEVICE MARKET,
THROUGH 2020 ($ MILLIONS) 80
TABLE 20 GLOBAL DIGITAL IN VITRO AND OTHER DIAGNOSTIC DEVICES MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 81
AUTOMATED HEMATOLOGY ANALYZERS AND BLOOD CELL COUNTERS 81
HEMATOLOGY ANALYZER COMPONENTS AND MECHANICS 84
HEMATOLOGY INSTRUMENT SOFTWARE 85
HEMATOLOGY INSTRUMENTATION FROM THE MANUFACTURER'S
PERSPECTIVE 85
ADVANCED HEMATOLOGY ANALYZER MODEL MARKET 86
STANDARD HEMATOLOGY ANALYZER MODEL MARKET 86
DIGITAL CELL COUNTER FEATURES 87
CURRENT PRODUCTS AND FEATURES 88
TABLE 21 GLOBAL AUTOMATED HEMATOLOGY ANALYZER AND BLOOD CELL
COUNTER MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 88
DIGITAL CHROMOSOME ANALYZERS 88
TABLE 22 GLOBAL DIGITAL CHROMOSOME ANALYZER MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 90
FLUORESCENCE IN SITU HYBRIDIZATION ENUMERATION SYSTEMS 90
TABLE 23 GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION ENUMERATION SYSTEM
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 91
DIGITAL URINE SEDIMENT ANALYZERS 91
TABLE 24 GLOBAL DIGITAL URINE SEDIMENT ANALYZER MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 93
IMMUNOHISTOCHEMISTRY IMAGE ANALYSIS APPLICATIONS 93
TABLE 25 GLOBAL IMMUNOHISTOCHEMISTRY IMAGE ANALYSIS APPLICATION
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 94
DIGITAL CYTOPATHOLOGY 94
TABLE 26 GLOBAL DIGITAL CYTOPATHOLOGY MARKET BY REGION, THROUGH 2020
($ MILLIONS) 95
DIGITAL POLYMERASE CHAIN REACTION 95
DIGITAL POLYMERASE CHAIN REACTION APPLICATIONS 96
DIGITAL POLYMERASE CHAIN REACTION ADVANTAGES 96
REAL-TIME VERSUS TRADITIONAL VERSUS DIGITAL POLYMERASE CHAIN
REACTION 96
TABLE 27 GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 97
SIGNET CELL DETECTION 98
TABLE 28 GLOBAL SIGNET CELL DETECTION MARKET BY REGION, THROUGH 2020
($ MILLIONS) 98
DIGITAL HOLOGRAPHIC MICROSCOPY 99
TABLE 29 GLOBAL DIGITAL HOLOGRAPHIC MICROSCOPY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 100
CHAPTER 6 PATHOLOGY MARKET TYPES 102
TABLE 30 GLOBAL DIGITAL PATHOLOGY MARKET BY TYPE, THROUGH 2020 ($
MILLIONS) 102
ANATOMICAL PATHOLOGY 102
KEY CONSIDERATION FOR INTEGRATING DIGITAL PATHOLOGY SYSTEMS
WITH ANATOMY PATHOLOGY LABORATORY INFORMATION SYSTEMS 103
TABLE 31 GLOBAL DIGITAL PATHOLOGY IN THE ANATOMIC PATHOLOGY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 104
GENETIC PATHOLOGY 105
TABLE 32 GLOBAL DIGITAL PATHOLOGY IN GENETIC PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 106
HEMATOLOGY AND CLINICAL PATHOLOGY 106
TABLE 33 GLOBAL DIGITAL PATHOLOGY IN HEMATOLOGY AND CLINICAL
PATHOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 107
IMMUNOPATHOLOGY 108
TABLE 34 GLOBAL DIGITAL PATHOLOGY IN IMMUNOPATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 108
CHEMICAL PATHOLOGY 108
TABLE 35 GLOBAL DIGITAL PATHOLOGY IN CHEMICAL PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 109
FORENSIC PATHOLOGY 109
TABLE 36 GLOBAL DIGITAL PATHOLOGY IN FORENSIC PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 110
MICROBIOLOGY 110
TABLE 37 GLOBAL DIGITAL PATHOLOGY IN MICROBIOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 111
CHAPTER 7 DIGITAL PATHOLOGY APPLICATION MARKET 113
TABLE 38 GLOBAL DIGITAL PATHOLOGY MARKET BY APPLICATION, THROUGH 2020
($ MILLIONS) 113
DISEASE DIAGNOSIS 113
TABLE 39 GLOBAL DIGITAL PATHOLOGY IN DISEASE DIAGNOSIS MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 114
DRUG DISCOVERY AND DRUG DEVELOPMENT 114
DIGITAL IMAGE USES 115
TABLE 40 GLOBAL DIGITAL PATHOLOGY IN DRUG DISCOVERY AND DRUG
DEVELOPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 117
RESEARCH AND DEVELOPMENT 117
TABLE 41 GLOBAL DIGITAL PATHOLOGY IN RESEARCH AND DEVELOPMENT BY
REGION, THROUGH 2020 ($ MILLIONS) 118
CHAPTER 8 END-USER MARKET 120
TABLE 42 GLOBAL DIGITAL PATHOLOGY MARKET BY END USER, THROUGH 2020 ($
MILLIONS) 120
BIOTECH AND PHARMA COMPANIES 120
TABLE 43 GLOBAL DIGITAL PATHOLOGY IN BIOTECH AND PHARMACEUTICAL
COMPANIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 122
HOSPITALS AND DIAGNOSTIC CENTERS 123
TABLE 44 GLOBAL DIGITAL PATHOLOGY IN HOSPITALS AND DIAGNOSTIC CENTERS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 125
ACADEMIC CENTERS: CONSULTING AND TRAINING 125
TABLE 45 GLOBAL DIGITAL PATHOLOGY IN ACADEMIC CENTERS, CONSULTING AND
TRAINING MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 127
CHAPTER 9 COMPETITIVE LANDSCAPE 129
NEW PRODUCT DEVELOPMENT 129
TABLE 46 NEW PRODUCTS BY COMPANY, 2011-2015 130
FIGURE 8 NEW PRODUCT DEVELOPMENT BY COMPANY, 2011-2015 (%) 135
AGREEMENTS AND COLLABORATIONS 136
FIGURE 9 AGREEMENTS AND COLLABORATIONS BY COMPANY, 2011-2015 (%) 136
TABLE 47 AGREEMENTS AND COLLABORATIONS BY COMPANY, 2011-2015 138
PRODUCT APPROVALS 143
FIGURE 10 PRODUCT APPROVALS BY COMPANY, 2011-2015 (%) 143
TABLE 48 PRODUCT APPROVALS BY COMPANY, 2011-2015 144
MERGERS AND ACQUISITIONS 146
TABLE 49 MERGERS AND ACQUISITIONS BY COMPANY, 2011-2015 146
OTHER STRATEGIES 147
TABLE 50 OTHER STRATEGIES BY COMPANY, 2011-2015 147
CHAPTER 10 REGIONAL ANALYSIS 150
NORTH AMERICA 150
TABLE 51 NORTH AMERICAN DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($
MILLIONS) 151
EUROPE 151
CASE STUDY: IMPLEMENTATION ISSUES FOR VIRTUAL MICROSCOPY IN
EUROPE 152
TABLE 52 EUROPEAN DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($ MILLIONS) 153
ASIA 153
CHINA 153
INDIA 154
TABLE 53 ASIAN DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($ MILLIONS) 155
REST OF THE WORLD 155
TABLE 54 REST OF WORLD DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($
MILLIONS) 156
CHAPTER 11 PATENT ANALYSIS 158
U.S. PATENT ANALYSIS 158
FIGURE 11 U.S. PATENTS BY TECHNOLOGY, 2011-2015 (%) 158
FIGURE 12 U.S. PATENTS BY COMPANY, 2011-2015 (%) 159
EUROPEAN PATENT ANALYSIS 160
FIGURE 13 EUROPEAN PATENTS BY TECHNOLOGY, 2011-2015 (%) 160
FIGURE 14 EUROPEAN PATENTS BY COMPANIES, 2011-2015 (%) 161
JAPANESE PATENT ANALYSIS 162
FIGURE 15 JAPANESE PATENTS BY TECHNOLOGY, 2011-2015 (%) 162
FIGURE 16 JAPANESE PATENTS BY COMPANY, 2011-2015 (%) 163
CHAPTER 12 COMPANY PROFILES 165
3DHISTECH LTD. 165
TABLE 55 3DHISTECH LTD. PRODUCT PORTFOLIO 165
TABLE 56 3DHISTECH LTD. RECENT DEVELOPMENTS 166
APOLLO PACS INC. 166
TABLE 57 APOLLO PACS INC. PRODUCT PORTFOLIO 166
TABLE 58 APOLLO PACS INC. RECENT DEVELOPMENTS 166
AURORA INTERACTIVE LTD. 167
TABLE 59 AURORA INTERACTIVE LTD. PRODUCT PORTFOLIO 167
TABLE 60 AURORA INTERACTIVE LTD. RECENT DEVELOPMENTS 168
CORISTA LLC 168
TABLE 61 CORISTA LLC PRODUCT PORTFOLIO 168
TABLE 62 CORISTA LLC RECENT DEVELOPMENTS 169
DEFINIENS AG 169
TABLE 63 DEFINIENS AG PRODUCT PORTFOLIO 169
TABLE 64 DEFINIENS AG RECENT DEVELOPMENTS 170
DIGIPATH INC. 171
TABLE 65 DIGIPATH INC. PRODUCT PORTFOLIO 171
TABLE 66 DIGIPATH INC. FINANCIALS, 2014-2011 ($ MILLIONS) 171
TABLE 67 DIGIPATH INC. RECENT DEVELOPMENTS 172
HURON DIGITAL PATHOLOGY INC. 172
TABLE 68 HURON DIGITAL PATHOLOGY PRODUCT PORTFOLIO 172
TABLE 69 HURON DIGITAL PATHOLOGY'S RECENT DEVELOPMENTS 173
INDICA LABS INC. 174
TABLE 70 INDICA LABS INC. PRODUCT PORTFOLIO 174
TABLE 71 INDICA LABS INC. RECENT DEVELOPMENTS 175
LEICA BIOSYSTEMS INC 175
TABLE 72 LEICA BIOSYSTEMS INC. PRODUCT PORTFOLIO 176
TABLE 73 LEICA BIOSYSTEMS INC. RECENT DEVELOPMENTS 176
LEICA MICROSYSTEMS GMBH 177
TABLE 74 LEICA MICROSYSTEMS GMBH PRODUCT PORTFOLIO 177
TABLE 75 LEICA MICROSYSTEMS GMBH RECENT DEVELOPMENTS, 2013-2015 178
LIGOLAB LLC 180
TABLE 76 LIGOLAB LLC PRODUCT PORTFOLIO 180
MIKROSCAN TECHNOLOGIES INC. 180
TABLE 77 MIKROSCAN TECHNOLOGIES INC. PRODUCT PORTFOLIO 181
TABLE 78 MIKROSCAN TECHNOLOGIES INC. RECENT DEVELOPMENTS 181
NIKON INSTRUMENTS INC. 182
TABLE 79 NIKON INSTRUMENTS INC. PRODUCT PORTFOLIO 182
TABLE 80 NIKON INSTRUMENTS INC. FINANCIALS, 2011-2013 ($ MILLIONS) 182
TABLE 81 NIKON INSTRUMENTS INC. RECENT DEVELOPMENTS 183
OMNYX LLC 184
TABLE 82 OMNYX LLC PRODUCT PORTFOLIO 184
TABLE 83 OMNYX LLC RECENT DEVELOPMENTS 184
PATHCENTRAL INC. 185
TABLE 84 PATHCENTRAL PRODUCT PORTFOLIO 185
TABLE 85 PATHCENTRAL RECENT DEVELOPMENTS, 2011-2013 185
PATHXL 186
TABLE 86 PATHXL PRODUCT PORTFOLIO 186
TABLE 87 PATHXL RECENT DEVELOPMENTS, 2011-2013 187
PIXCELLDATA LTD. 187
TABLE 88 PIXCELLDATA LTD PRODUCT PORTFOLIO 188
TABLE 89 PIXCELLDATA LTD. RECENT DEVELOPMENTS, 2011-2013 188
SUNQUEST INFORMATION SYSTEMS 189
TABLE 90 SUNQUEST INFORMATION SYSTEMS PRODUCT PORTFOLIO 189
TABLE 91 SUNQUEST INFORMATION SYSTEMS RECENT DEVELOPMENTS,
2013-2015 190
VENTANA MEDICAL SYSTEMS INC. 190
TABLE 92 VENTANA MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO 191
TABLE 93 VENTANA MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2011-2015 191
VISIOPHARM 193
TABLE 94 VISIOPHARM PRODUCT PORTFOLIO 193
TABLE 95 VISIOPHARM RECENT DEVELOPMENTS, 2011-2013 194
XIFIN 195
TABLE 96 XIFIN PRODUCT PORTFOLIO 195
TABLE 97 XIFIN RECENT DEVELOPMENTS 196
CHAPTER 13 APPENDIX 198
PATENT LIST 198
TABLE 98 PATENT LIST, 2011-2015 198

LIST OF TABLES

SUMMARY TABLE GLOBAL DIGITAL PATHOLOGY MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 8
TABLE 1 GLOBAL DIGITAL PATHOLOGY MARKET BY SYSTEM, THROUGH 2020 ($
MILLIONS) 52
TABLE 2 GLOBAL DIGITAL PATHOLOGY DEVICE MARKET BY TYPE, THROUGH 2020 ($
MILLIONS) 52
TABLE 3 GLOBAL DIGITAL PATHOLOGY DEVICE MARKET BY REGION, THROUGH 2020
($ MILLIONS) 53
TABLE 4 GLOBAL DIGITAL CAMERAS IN THE DIGITAL PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 55
TABLE 5 GLOBAL ROBOTIC MICROSCOPES IN DIGITAL PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 58
TABLE 6 GLOBAL SCANNERS IN DIGITAL PATHOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 59
TABLE 7 GLOBAL DIGITAL PATHOLOGY ANALYTIC MARKET BY PLATFORM, THROUGH
2020 ($ MILLIONS) 61
TABLE 8 GLOBAL DIGITAL PATHOLOGY ANALYTIC MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 61
TABLE 9 GLOBAL DIGITAL PATHOLOGY VISUALIZATION AND IMAGE ANALYSIS
PLATFORM MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 64
TABLE 10 GLOBAL DIGITAL PATHOLOGY INFORMATION SYSTEM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 66
TABLE 11 GLOBAL DIGITAL PATHOLOGY STORAGE PLATFORM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 69
TABLE 12 GLOBAL DIGITAL PATHOLOGY COMMUNICATION PLATFORM MARKET,
THROUGH 2020 ($ MILLIONS) 69
TABLE 13 GLOBAL DIGITAL PATHOLOGY COMMUNICATION PLATFORM MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 71
TABLE 14 GLOBAL TELEPATHOLOGY SYSTEM MARKET BY TYPE, THROUGH 2020 ($
MILLIONS) 72
TABLE 15 GLOBAL TELEPATHOLOGY SYSTEM MARKET BY REGION, THROUGH 2020
($ MILLIONS) 72
TABLE 16 GLOBAL STATIC TELEPATHOLOGY SYSTEM MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 74
TABLE 17 GLOBAL HYBRID TELEPATHOLOGY SYSTEM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 76
TABLE 18 GLOBAL REAL-TIME TELEPATHOLOGY SYSTEM MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 78
TABLE 19 GLOBAL DIGITAL IN VITRO AND OTHER DIAGNOSTIC DEVICE MARKET,
THROUGH 2020 ($ MILLIONS) 80
TABLE 20 GLOBAL DIGITAL IN VITRO AND OTHER DIAGNOSTIC DEVICES MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 81
TABLE 21 GLOBAL AUTOMATED HEMATOLOGY ANALYZER AND BLOOD CELL
COUNTER MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 88
TABLE 22 GLOBAL DIGITAL CHROMOSOME ANALYZER MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 90
TABLE 23 GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION ENUMERATION SYSTEM
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 91
TABLE 24 GLOBAL DIGITAL URINE SEDIMENT ANALYZER MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 93
TABLE 25 GLOBAL IMMUNOHISTOCHEMISTRY IMAGE ANALYSIS APPLICATION
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 94
TABLE 26 GLOBAL DIGITAL CYTOPATHOLOGY MARKET BY REGION, THROUGH 2020
($ MILLIONS) 95
TABLE 27 GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 97
TABLE 28 GLOBAL SIGNET CELL DETECTION MARKET BY REGION, THROUGH 2020 ($
MILLIONS) 98
TABLE 29 GLOBAL DIGITAL HOLOGRAPHIC MICROSCOPY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 100
TABLE 30 GLOBAL DIGITAL PATHOLOGY MARKET BY TYPE, THROUGH 2020 ($
MILLIONS) 102
TABLE 31 GLOBAL DIGITAL PATHOLOGY IN THE ANATOMIC PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 104
TABLE 32 GLOBAL DIGITAL PATHOLOGY IN GENETIC PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 106
TABLE 33 GLOBAL DIGITAL PATHOLOGY IN HEMATOLOGY AND CLINICAL
PATHOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 107
TABLE 34 GLOBAL DIGITAL PATHOLOGY IN IMMUNOPATHOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 108
TABLE 35 GLOBAL DIGITAL PATHOLOGY IN CHEMICAL PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 109
TABLE 36 GLOBAL DIGITAL PATHOLOGY IN FORENSIC PATHOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 110
TABLE 37 GLOBAL DIGITAL PATHOLOGY IN MICROBIOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 111
TABLE 38 GLOBAL DIGITAL PATHOLOGY MARKET BY APPLICATION, THROUGH 2020
($ MILLIONS) 113
TABLE 39 GLOBAL DIGITAL PATHOLOGY IN DISEASE DIAGNOSIS MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 114
TABLE 40 GLOBAL DIGITAL PATHOLOGY IN DRUG DISCOVERY AND DRUG
DEVELOPMENT MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 117
TABLE 41 GLOBAL DIGITAL PATHOLOGY IN RESEARCH AND DEVELOPMENT BY
REGION, THROUGH 2020 ($ MILLIONS) 118
TABLE 42 GLOBAL DIGITAL PATHOLOGY MARKET BY END USER, THROUGH 2020 ($
MILLIONS) 120
TABLE 43 GLOBAL DIGITAL PATHOLOGY IN BIOTECH AND PHARMACEUTICAL
COMPANIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 122
TABLE 44 GLOBAL DIGITAL PATHOLOGY IN HOSPITALS AND DIAGNOSTIC CENTERS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 125
TABLE 45 GLOBAL DIGITAL PATHOLOGY IN ACADEMIC CENTERS, CONSULTING AND
TRAINING MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 127
TABLE 46 NEW PRODUCTS BY COMPANY, 2011-2015 130
TABLE 47 AGREEMENTS AND COLLABORATIONS BY COMPANY, 2011-2015 138
TABLE 48 PRODUCT APPROVALS BY COMPANY, 2011-2015 144
TABLE 49 MERGERS AND ACQUISITIONS BY COMPANY, 2011-2015 146
TABLE 50 OTHER STRATEGIES BY COMPANY, 2011-2015 147
TABLE 51 NORTH AMERICAN DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($
MILLIONS) 151
TABLE 52 EUROPEAN DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($ MILLIONS) 153
TABLE 53 ASIAN DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($ MILLIONS) 155
TABLE 54 REST OF WORLD DIGITAL PATHOLOGY MARKET, THROUGH 2020 ($
MILLIONS) 156
TABLE 55 3DHISTECH LTD. PRODUCT PORTFOLIO 165
TABLE 56 3DHISTECH LTD. RECENT DEVELOPMENTS 166
TABLE 57 APOLLO PACS INC. PRODUCT PORTFOLIO 166
TABLE 58 APOLLO PACS INC. RECENT DEVELOPMENTS 166
TABLE 59 AURORA INTERACTIVE LTD. PRODUCT PORTFOLIO 167
TABLE 60 AURORA INTERACTIVE LTD. RECENT DEVELOPMENTS 168
TABLE 61 CORISTA LLC PRODUCT PORTFOLIO 168
TABLE 62 CORISTA LLC RECENT DEVELOPMENTS 169
TABLE 63 DEFINIENS AG PRODUCT PORTFOLIO 169
TABLE 64 DEFINIENS AG RECENT DEVELOPMENTS 170
TABLE 65 DIGIPATH INC. PRODUCT PORTFOLIO 171
TABLE 66 DIGIPATH INC. FINANCIALS, 2014-2011 ($ MILLIONS) 171
TABLE 67 DIGIPATH INC. RECENT DEVELOPMENTS 172
TABLE 68 HURON DIGITAL PATHOLOGY PRODUCT PORTFOLIO 172
TABLE 69 HURON DIGITAL PATHOLOGY'S RECENT DEVELOPMENTS 173
TABLE 70 INDICA LABS INC. PRODUCT PORTFOLIO 174
TABLE 71 INDICA LABS INC. RECENT DEVELOPMENTS 175
TABLE 72 LEICA BIOSYSTEMS INC. PRODUCT PORTFOLIO 176
TABLE 73 LEICA BIOSYSTEMS INC. RECENT DEVELOPMENTS 176
TABLE 74 LEICA MICROSYSTEMS GMBH PRODUCT PORTFOLIO 177
TABLE 75 LEICA MICROSYSTEMS GMBH RECENT DEVELOPMENTS, 2013-2015 178
TABLE 76 LIGOLAB LLC PRODUCT PORTFOLIO 180
TABLE 77 MIKROSCAN TECHNOLOGIES INC. PRODUCT PORTFOLIO 181
TABLE 78 MIKROSCAN TECHNOLOGIES INC. RECENT DEVELOPMENTS 181
TABLE 79 NIKON INSTRUMENTS INC. PRODUCT PORTFOLIO 182
TABLE 80 NIKON INSTRUMENTS INC. FINANCIALS, 2011-2013 ($ MILLIONS) 182
TABLE 81 NIKON INSTRUMENTS INC. RECENT DEVELOPMENTS 183
TABLE 82 OMNYX LLC PRODUCT PORTFOLIO 184
TABLE 83 OMNYX LLC RECENT DEVELOPMENTS 184
TABLE 84 PATHCENTRAL PRODUCT PORTFOLIO 185
TABLE 85 PATHCENTRAL RECENT DEVELOPMENTS, 2011-2013 185
TABLE 86 PATHXL PRODUCT PORTFOLIO 186
TABLE 87 PATHXL RECENT DEVELOPMENTS, 2011-2013 187
TABLE 88 PIXCELLDATA LTD PRODUCT PORTFOLIO 188
TABLE 89 PIXCELLDATA LTD. RECENT DEVELOPMENTS, 2011-2013 188
TABLE 90 SUNQUEST INFORMATION SYSTEMS PRODUCT PORTFOLIO 189
TABLE 91 SUNQUEST INFORMATION SYSTEMS RECENT DEVELOPMENTS, 2013-2015 190
TABLE 92 VENTANA MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO 191
TABLE 93 VENTANA MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2011-2015 191
TABLE 94 VISIOPHARM PRODUCT PORTFOLIO 193
TABLE 95 VISIOPHARM RECENT DEVELOPMENTS, 2011-2013 194
TABLE 96 XIFIN PRODUCT PORTFOLIO 195
TABLE 97 XIFIN RECENT DEVELOPMENTS 196
TABLE 98 PATENT LIST, 2011-2015 198

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Digital Pathology Industry, 2016 Market Research Report

Global and Chinese Digital Pathology Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Digital Pathology Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Digital Pathology industry with a focus ...

Global Digital Pathology Analytics Market Research Report 2016

Global Digital Pathology Analytics Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Digital Pathology Analytics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Digital Pathology Analytics industry, focusing ...

Global Pathology Devices Market Research Report 2016

Global Pathology Devices Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Pathology Devices Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Pathology Devices industry, focusing on the main regions ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.